Lavocestine

Carbocisteine, the active ingredient in Lavocestine, is a mucolytic presented as an oral formulation for oral use. It helps reduce thick mucus in the airways and is used in patients with chronic bronchitis, COPD, asthma with mucus hypersecretion, and respiratory infections characterized by viscous sputum.

GNH USA supplies Lavocestine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides batch‑tested product for global distribution with full regulatory documentation and reliable logistics support.

Carbocisteine is a mucolytic agent that reduces mucus viscosity in chronic respiratory conditions. - Chronic bronchitis: improves sputum clearance and reduces cough frequency. - Chronic obstructive pulmonary disease (COPD): facilitates airway drainage and eases breathing effort. - Asthma with mucus hypersecretion: helps loosen airway secretions and supports bronchodilator therapy. - Respiratory tract infections with thick mucus: aids in thinning sputum to enhance expectoration.

Carbocisteine is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Abdominal discomfort

Serious or Rare Side Effects: - Severe allergic reactions such as rash, urticaria or anaphylaxis - Hepatic dysfunction manifested by elevated transaminases - Neutropenia or other blood dyscrasias

When prescribing carbocisteine, clinicians should consider the following precautions to ensure safe use. - Renal function assessment: adjust use in patients with severe renal impairment. - Hepatic monitoring: observe liver enzymes in individuals with known liver disease. - Gastrointestinal tolerance: monitor for persistent nausea, vomiting or diarrhea. - Hypersensitivity history: avoid in patients with documented allergy to carbocisteine or related compounds. - Pregnancy and lactation: use only if the potential benefit outweighs the unknown risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Carbocisteine may interact with other medicines; awareness of key interactions helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Co‑administration with other mucolytic agents: may cause excessive thinning of mucus and respiratory irritation. - Known hypersensitivity to related thiol‑containing drugs: risk of severe allergic response.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: can decrease carbocisteine absorption; separate dosing by at least 2 hours. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): combined use may increase gastrointestinal discomfort. - Macrolide antibiotics (e.g., erythromycin): may potentiate gastrointestinal side effects.